SCHEMBL21557500

SCHEMBL21557500

COC(=O)C1CCc2cc(-c3ccccn3)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.42
GSK3B P49841 1/20 0.42
DYRK1A Q13627 1/20 0.42
BCR P11274 1/20 0.42
FAAH O00519 4/20 0.41
AXL P30530 1/20 0.41
KCNH2 Q12809 1/20 0.39
MCHR1 Q99705 1/20 0.39
KAT6A Q92794 1/20 0.39
CYP1A2 P05177 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HCRTR1 O43613 3/20 0.39
HCRTR2 O43614 3/20 0.39
CNR1 P21554 1/20 0.38
P2RX7 Q99572 1/20 0.38
SCN9A Q15858 1/20 0.38
DHODH Q02127 1/20 0.38
PDE5A O76074 1/20 0.38
MAP4K4 O95819 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21557614 0.93 F2 (0.44) ABL1GSK3BDYRK1ABCRFAAH
SCHEMBL21557499 0.85 MAP4K4 (0.50) ABL1GSK3BDYRK1AFAAHKCNH2
SCHEMBL21557568 0.79 ABL1 (0.42) ABL1GSK3BDYRK1ABCRAXL
SCHEMBL21557622 0.78 F2 (0.47) ABL1GSK3BDYRK1AFAAHKAT6A
SCHEMBL2813791 0.77 AKR1C3 (0.42) ABL1BCRPDE5AMAP4K4
SCHEMBL12891743 0.77 DRD2 (0.41) ABL1GSK3BDYRK1AFAAHKCNH2
SCHEMBL26820010 0.77 DRD2 (0.41) ABL1GSK3BDYRK1AFAAHKCNH2
SCHEMBL12891748 0.77 DRD2 (0.41) ABL1GSK3BDYRK1AFAAHKCNH2
SCHEMBL21557578 0.77 FAAH (0.54) ABL1GSK3BDYRK1AFAAHAXL
SCHEMBL1153666 0.74 PIN1 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647710-B2 Thiazole derivative and applications thereof MEDSHINE DISCOVERY INC. (CN) 2020-05-12 US disclosed
EP-3566749-A1 THIAZOLE DERIVATIVE AND APPLICATIONS THEREOF Medshine Discovery Inc. (CN) 2019-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647710-B2 Thiazole derivative and applications thereof TSLP, TK2, TK1 ABL1 881/4885GSK3B 1337/4885DYRK1A 2901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.